It was great to attend Formulation & Delivery Europe 2026 in Basel last month – a valuable opportunity to explore the latest industry trends in drug formulation and delivery, connect with industry experts to build collaborations, and discuss the technologies shaping the future of healthcare.

Innovation is moving quickly in combination products and alternative routes of administration, thus it was an excellent time to gain new insights and make connections that will support Calla Lily Clinical Care as we continue developing Callavid® and beyond.